Product Search
News
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Jul/26
- Announcement of Financial Results 1Q, FY2019
- 2019/Jul/19
- Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”)
- 2019/Jun/21
- Shareholders' Meeting has been updated
- 2019/Jun/18
- Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN® Tape in Japan
- 2019/Jun/12
- Annual Investors' Meeting Update - Webcast Replay
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Jul/19
- Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”)
- 2019/Jun/18
- Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN® Tape in Japan
- 2019/Jun/07
- Launch of Bisono® Tape 2mg, a Transdermal Patch Containing a β1 Blocker
- 2019/Apr/18
- Established a Collaborative Research Department for the Development of New Nucleic Acid Drugs
- 2019/Feb/27
- The Nitto ATP Finals charitable activities in support of UNICEF
